# Strategy for Aortic Surgery Hemostasis

Study · id `cardio:ct-nct03917862` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03917862](<https://clinicaltrials.gov/study/NCT03917862>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03917862

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT03917862. Randomized; no masking; primary purpose treatment. Start 2018-12-04 (actual); primary completion 2020-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT03917862, source copy `cardio:ctgov-nct03917862-2019-04-17`, retrieved 2026-11-18)
- Started: 2018-12-04 (actual) (ClinicalTrials.gov record NCT03917862, source copy `cardio:ctgov-nct03917862-2019-04-17`, retrieved 2026-11-18)
- Primary completion: 2020-12 (anticipated) (ClinicalTrials.gov record NCT03917862, source copy `cardio:ctgov-nct03917862-2019-04-17`, retrieved 2026-11-18)
- Completion: 2020-12 (anticipated) (ClinicalTrials.gov record NCT03917862, source copy `cardio:ctgov-nct03917862-2019-04-17`, retrieved 2026-11-18)
- Countries: Brazil (ClinicalTrials.gov record NCT03917862, source copy `cardio:ctgov-nct03917862-2019-04-17`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03917862-2019-04-17`, retrieved 2026-11-18)

## The registry's words

- Brief title: Strategy for Aortic Surgery Hemostasis
- Acronym: SASH
- Condition: Ascending Aorta Abnormality
- Condition: Ascending Aortic Dissection
- Condition: Ascending Aorta Aneurysm
- Intervention (Combination product): TDM-621
- Lead sponsor: University of Sao Paulo General Hospital
- Lead sponsor class: OTHER
- Collaborator: 3-D Matrix UK Ltd.
- Collaborator class: INDUSTRY
- Collaborator: InCor Heart Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry condition terms include this condition: Aortic dissection (`cardio:aortic-dissection`)
- Registry condition terms include this condition: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: University of Sao Paulo General Hospital (`cardio:org-university-of-sao-paulo-general-hospital`)
- Registry lists this organization as a collaborator: InCor Heart Institute (`cardio:org-incor-heart-institute`)

## Provenance

Content hash: ef0dad00be7849fbe3bb0ad88604954ccdb30ee8afb24cdba816dc9be5bb82dc
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
